ÂÜÀòÂÒÂ×

Susan Berland is a Board Member at Senti Biosciences. Susan was previously Acting Chief Financial Officer at Bluestar Genomics, Inc from May 2020 to August 2021. Prior to that, they served as Chief Financial Officer at Atreca, Inc. from January 2015 to December 2019.

At Bluestar Genomics, Susan provided executive finance operations support and helped develop a long-term capital & fundraising strategy to broaden the investor base. During their time at Atreca, they served as a trusted partner to the CEO and Board of Directors, professionalized the finance function, and played a leadership role in securing funding and laying the foundation for a successful IPO.

Susan was instrumental in establishing a research operation located within a Singapore R&D institute while at Atreca. Susan partnered with counsel to set up the entity and oversaw all financial operations of the subsidiary.

Susan Berland has a Bachelor of Arts from Lubar College of Business, a Master of Business Administration from Lubar College of Business, and has completed Executive Education: Succeeding as a Corporate Director from Harvard Business School. Susan also studied Environmental design and fine arts studies at Parsons School of Design - The New School, and completed a foreign student program with a focus on language, history, and cultural studies at The Hebrew University of Jerusalem.